| Name | Antitumor agent-45 |
|---|---|
| Synonyms | 1,8-Naphthyridine-3-cboxamide, 1-(4-bromophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-1,4-dihydro-4-oxo |
| Description | Antitumor agent-45 (Compound 21) could induce and stimulate A549 cells apoptosis in G0/G1 and G2/M phase. Antitumor agent-45 (Compound 21) inhibits c-Met expression to regulate the growth of tumor cells[1]. |
|---|---|
| Related Catalog | |
| In Vitro | Antitumor agent-45 (Compound 21) enhibits IC50 values of 1.06, 10.87 and 0.11 μM in A549, Hela and MCF-7 cells, respectively[1]. |
| References |
| Molecular Formula | C28H17BrFN5O3 |
|---|---|
| Molecular Weight | 570.37 |